EP
CNCE

Elkfork Partners’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Elkfork Partners’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-14,146
Closed -$324K – 1036
2018
Q1 		$324K Buy
+14,146
New +$324K 0.01% 652